BeyondSpring Inc. Proceeds from Issuance of Debt
BeyondSpring Inc. (BYSI) reported Proceeds from Issuance of Debt of $286.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfDebt · last filed 2026-03-25
- BeyondSpring Inc. proceeds from issuance of debt for the quarter ending 2025-12-31 was $5.00K.
- BeyondSpring Inc. proceeds from issuance of debt for the quarter ending 2024-12-31 was -$157.00K.
- BeyondSpring Inc. proceeds from issuance of debt for fiscal 2025 was $286.00K, a 92.69% decline from fiscal 2024.
- BeyondSpring Inc. proceeds from issuance of debt for fiscal 2024 was $3.91M.
- BeyondSpring Inc. proceeds from issuance of debt for fiscal 2023 was $0.00.
| Period end | Proceeds from Issuance of Debt 3 month | Proceeds from Issuance of Debt 9 month | Proceeds from Issuance of Debt 12 month |
|---|---|---|---|
| 2025-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $286.00K 10-K · filed 2026-03-25 | |
| 2025-09-30 | $281.00K 10-Q · filed 2025-11-12 | ||
| 2024-12-31 | -$157.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $3.91M 10-K · filed 2026-03-25 | |
| 2024-09-30 | $4.07M 10-Q · filed 2025-11-12 | ||
| 2023-12-31 | $0.00 10-K · filed 2025-03-27 | ||
| 2015-12-31 | $1.00M 20-F · filed 2018-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |